Mobile

A double blind comparative and randomised study in healthy adults of the safety, tolerability, and immunogenicity of PNEUMOVAX®II formulated with either all new process polysaccharides or all current ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-002789-12

A double blind comparative and randomised study in healthy adults of the safety, tolerability, and immunogenicity of PNEUMOVAX®II formulated with either all new process polysaccharides or all current process polysaccharides

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the post-vaccination geometric mean titres (GMTs) of antibody to pneumococcal serotypes 3 and 8 in recipients of PNEUMOVAX®II formulated with all new process polysaccharides to the same antibody responses in recipients of PNEUMOVAX® II formulated with all current process polysaccharides.

Critère d'inclusion

  • Prevention of invasive pneumococcal disease (IPD)

Liens